千金药业：子公司3个药品拟中选全国集采

Core Viewpoint - Qianjin Pharmaceutical announced that its subsidiary, Qianjin Xiangjiang Pharmaceutical, participated in the 11th batch of national centralized drug procurement, with three products expected to be selected for procurement [1] Group 1: Selected Products and Pricing - Adenosylcobalamin capsules are expected to be selected at a price of 4.88 yuan per box, primarily supplying Hunan, Guangxi, and Guizhou [1] - Fluvoxamine tablets are expected to be selected at a price of 7.14 yuan per box, primarily supplying Zhejiang, Fujian, and Chongqing [1] - Dopamine hydrazine tablets are expected to be selected at a price of 18.88 yuan per box, primarily supplying Sichuan, Hebei, Tianjin, and Ningxia [1] Group 2: Market and Sales Outlook - As of the end of Q3 2025, these products have not generated sales in the domestic market [1] - The procurement cycle for selected products will be from the execution date of the selection results until December 31, 2028 [1]